393 related articles for article (PubMed ID: 26485179)
1. Induction of apoptosis in leukemia cell lines by new copper(II) complexes containing naphthyl groups via interaction with death receptors.
Fernandes C; Horn A; Lopes BF; Bull ES; Azeredo NFB; Kanashiro MM; Borges FV; Bortoluzzi AJ; Szpoganicz B; Pires AB; Franco RWA; Almeida JCA; Maciel LLF; Resende JALC; Schenk G
J Inorg Biochem; 2015 Dec; 153():68-87. PubMed ID: 26485179
[TBL] [Abstract][Full Text] [Related]
2. Modulating the antitumoral activity by the design of new platinum(II) compounds: Synthesis, characterization, DFT, ultrastructure and mechanistic studies.
Moreira RO; Morcelli SR; Kanashiro MM; Resende JALC; Maciel LLF; de A Almeida JC; Gahan LR; Horn A; Fernandes C
J Inorg Biochem; 2019 May; 194():200-213. PubMed ID: 30877895
[TBL] [Abstract][Full Text] [Related]
3. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
[TBL] [Abstract][Full Text] [Related]
4. Highly efficient synthetic iron-dependent nucleases activate both intrinsic and extrinsic apoptotic death pathways in leukemia cancer cells.
Horn A; Fernandes C; Parrilha GL; Kanashiro MM; Borges FV; de Melo EJ; Schenk G; Terenzi H; Pich CT
J Inorg Biochem; 2013 Nov; 128():38-47. PubMed ID: 23933562
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines.
Borges LJH; Bull ÉS; Fernandes C; Horn A; Azeredo NF; Resende JALC; Freitas WR; Carvalho ECQ; Lemos LS; Jerdy H; Kanashiro MM
Eur J Med Chem; 2016 Nov; 123():128-140. PubMed ID: 27474929
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and antitumoral activity of new cobalt(II)complexes: Effect of the ligand isomerism on the biological activity of the complexes.
Morcelli SR; Bull ÉS; Terra WS; Moreira RO; Borges FV; Kanashiro MM; Bortoluzzi AJ; Maciel LL; de A Almeida JC; Júnior AH; Fernandes C
J Inorg Biochem; 2016 Aug; 161():73-82. PubMed ID: 27221950
[TBL] [Abstract][Full Text] [Related]
7. Effect of the hydroxamate group in the antitumoral activity and toxicity toward normal cells of new copper(II) complexes.
Azeredo NFB; Borges FV; Mathias MS; Resende JALC; Franco RWA; Kanashiro MM; Horn A; Fernandes C
Biometals; 2021 Apr; 34(2):229-244. PubMed ID: 33559811
[TBL] [Abstract][Full Text] [Related]
8. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
[TBL] [Abstract][Full Text] [Related]
9. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.
Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M
J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic copper(II), cobalt(II), zinc(II), and nickel(II) coordination compounds of clotrimazole.
Betanzos-Lara S; Gómez-Ruiz C; Barrón-Sosa LR; Gracia-Mora I; Flores-Álamo M; Barba-Behrens N
J Inorg Biochem; 2012 Sep; 114():82-93. PubMed ID: 22717722
[TBL] [Abstract][Full Text] [Related]
11. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
12. Oxoaporphine Metal Complexes (Co
Qin JL; Shen WY; Chen ZF; Zhao LF; Qin QP; Yu YC; Liang H
Sci Rep; 2017 Apr; 7():46056. PubMed ID: 28436418
[TBL] [Abstract][Full Text] [Related]
13. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
[TBL] [Abstract][Full Text] [Related]
15. Thiosemicarbazone(s)-anchored water soluble mono- and bimetallic Cu(ii) complexes: enzyme-like activities, biomolecular interactions, anticancer property and real-time live cytotoxicity.
Balakrishnan N; Haribabu J; Dhanabalan AK; Swaminathan S; Sun S; Dibwe DF; Bhuvanesh N; Awale S; Karvembu R
Dalton Trans; 2020 Jul; 49(27):9411-9424. PubMed ID: 32589180
[TBL] [Abstract][Full Text] [Related]
16. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
[TBL] [Abstract][Full Text] [Related]
17. Dinuclear Cu(I) complexes of pyridyl-diazadiphosphetidines and aminobis(phosphonite) ligands: synthesis, structural studies and antiproliferative activity towards human cervical, colon carcinoma and breast cancer cells.
Rashid A; Ananthnag GS; Naik S; Mague JT; Panda D; Balakrishna MS
Dalton Trans; 2014 Aug; 43(29):11339-51. PubMed ID: 24922341
[TBL] [Abstract][Full Text] [Related]
18. Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity.
Massoud SS; Louka FR; Ducharme GT; Fischer RC; Mautner FA; Vančo J; Herchel R; Dvořák Z; Trávníček Z
J Inorg Biochem; 2018 Mar; 180():39-46. PubMed ID: 29232637
[TBL] [Abstract][Full Text] [Related]
19. Copper(II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-212.
Gutiérrez AG; Vázquez-Aguirre A; García-Ramos JC; Flores-Alamo M; Hernández-Lemus E; Ruiz-Azuara L; Mejía C
J Inorg Biochem; 2013 Sep; 126():17-25. PubMed ID: 23727332
[TBL] [Abstract][Full Text] [Related]
20. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
